UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Consumer healthcare giant born out of GSK-Pfizer tie-up
by Nam Doo-hyun
2018-12-20 14:40
Local firms rush to develop blinding disease treatments
by Nam Doo-hyun
2018-12-20 14:37
Astellas Korea rebuked for arbitrarily modifying trials
by Lee Hye-seon
2018-12-20 11:05
Daewoong to export BTX product to 3 countries
by Lee Han-soo
2018-12-20 10:40
Hanmi’s lung cancer drug fails to win breakthrough therapy designation
by Lee Han-soo
2018-12-20 10:40
라인
Bridge Bio, Daewoong to co-develop ulcerative colitis drug candidate
by Lee Han-soo
2018-12-20 10:39
Beta-cell preservation key for Korean diabetes patients
by Lee Han-soo
2018-12-19 15:55
Drugmaker booked for bribing doctors with propofol discounts
by Lee Hye-seon
2018-12-19 14:12
Handok to test new insomnia drug in phase-3 study
by Lee Hye-seon
2018-12-19 11:44
Bridge Biotherapeutics announces FDA Clearance for idiopathic pulmonary fibrosis treatment
by Lee Han-soo
2018-12-19 10:25
라인
Korea’s botulinum toxin exports rebound in November
by Nam Doo-hyun
2018-12-18 15:51
Will healthcare meetings restore investor confidence in pharmaceuticals?
by Nam Doo-hyun
2018-12-17 15:44
Shinpoong’s drug becomes first-line malaria treatment in Côte d'Ivoire
by Park Gi-taek
2018-12-17 14:20
Sanofi launches five P3 clinical trials for Hanmi’s diabetic drug
by Lee Han-soo
2018-12-14 15:17
New hepatitis C drugs compete in shrinking market
by Nam Doo-hyun
2018-12-14 15:14
라인
Yuyu unveils new osteoporosis treatment
by Lee Han-soo
2018-12-13 11:50
SK, Sanofi begins P1 clinical trials for next-gen pneumococcal vaccine
by Lee Han-soo
2018-12-12 17:22
Dong-A ST, Eugene Bell Foundation to supply tuberculosis drug to NK
by Lee Han-soo
2018-12-12 17:20
Handok to test diabetes-yslipidemia combo
by Lee Hye-seon
2018-12-12 16:18
CJ Healthcare, DGMIF to co-develop new drug
by Lee Han-soo
2018-12-12 13:56
-
이전
61
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top